ABSTRACT
The primary aim of this chapter is to discuss specific characteristics of intravenous (IV) cocaine use, which are relevant for programs to reduce risk behavior for human immunodeficiency virus (HIV-1) transmission and exposure.
- Journals
- Corporate
- Help & Contact
Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG© 2024 Informa UK Limited